Suchergebnisse - "1474-0338" OR "1744-764X"

PubPharm (4.933)

3481

The safety and efficacy of apixaban: where do we stand in 2013?

enthalten in: Expert opinion on drug safety | 2013

von de Souza Brito, F. | Lopes, R. | Alexander, J.

3482

Efficacy and safety of mipomersen sodium (Kynamro)

enthalten in: Expert opinion on drug safety | 2013

von Hovingh, K. | Besseling, J. | Kastelein, J.

3483

Safety evaluation of leflunomide in rheumatoid arthritis

enthalten in: Expert opinion on drug safety | 2013

von I Keen, H. | Conaghan, P. | Tett, S.

3484

2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines

enthalten in: Expert opinion on drug safety | 2013

von Cavero, I.

3485

Related articles

enthalten in: Expert opinion on drug safety | 2013

3486

Related articles

enthalten in: Expert opinion on drug safety | 2013

3487

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients : pooled analysis from 5 randomized studies

enthalten in: Expert opinion on drug safety | 2012

von Marcellin, P. | Roberts, S. | Reddy, K. | +8

3488

Safety and efficacy evaluation of ambrisentan in pulmonary hypertension

enthalten in: Expert opinion on drug safety | 2012

von Vizza, C. | Fedele, F. | Pezzuto, B. | +1

3489

Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease

enthalten in: Expert opinion on drug safety | 2012

von Saha, S. | Wald, A.

3490

Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease

enthalten in: Expert opinion on drug safety | 2012

von Del Vecchio, L. | Locatelli, F.

CommentIn: Expert Opin Drug Saf. 2012 Nov;11(6):885-7. - PMID 22998694